切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2021, Vol. 10 ›› Issue (03) : 263 -268. doi: 10.3877/cma.j.issn.2095-3232.2021.03.007

所属专题: 文献

临床研究

三维重建在腹腔镜肝癌肝切除术中应用价值的Meta分析
张宇波1, 谢晓东1, 赵鹏1, 马伟忠1, 唐超峰2, 雷鹏2,()   
  1. 1. 750004 银川,宁夏医科大学临床医学院
    2. 750004 银川,宁夏医科大学总医院肝胆外科
  • 收稿日期:2021-02-23 出版日期:2021-06-10
  • 通信作者: 雷鹏
  • 基金资助:
    宁夏重点研发计划项目(2018BEG03001)

Application value of three-dimensional reconstruction in laparoscopic hepatectomy for liver cancer: a Meta-analysis

Yubo Zhang1, Xiaodong Xie1, Peng Zhao1, Weizhong Ma1, Chaofeng Tang2, Peng Lei2,()   

  1. 1. School of Clinical Medicine, Ningxia Medical University, Yinchuan 750004, China
    2. Department of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan 750004, China
  • Received:2021-02-23 Published:2021-06-10
  • Corresponding author: Peng Lei
引用本文:

张宇波, 谢晓东, 赵鹏, 马伟忠, 唐超峰, 雷鹏. 三维重建在腹腔镜肝癌肝切除术中应用价值的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2021, 10(03): 263-268.

Yubo Zhang, Xiaodong Xie, Peng Zhao, Weizhong Ma, Chaofeng Tang, Peng Lei. Application value of three-dimensional reconstruction in laparoscopic hepatectomy for liver cancer: a Meta-analysis[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2021, 10(03): 263-268.

目的

探讨三维重建在腹腔镜肝癌肝切除术的应用价值。

方法

在PubMed、Cochrane Library、Embase、中国生物医学文献、CNKI、万方、维普数据库检索从建库至2019年2月期间发表的关于三维重建联合腹腔镜肝切除治疗肝肿瘤的随机对照研究(RCT)、队列研究或病例对照研究的中英文文献。中文检索词主要包括肝肿瘤、肝癌、肝切除、腹腔镜、三维重建;英文检索词主要包括hepatoma、hepatectomy、laparoscope、three-dimensional reconstruction。对纳入文献提取手术情况及术后肝功能等数据进行Meta分析。

结果

最终纳入符合标准的文献8篇,共534例患者,其中采用三维重建的实验组245例,对照组289例。Meta分析结果显示,实验组与对照组手术时间(MD=-36.48,95%CI:-52.00~-20.96,Z=4.61,P<0.05)、术中出血量(MD=-109.36,95%CI:-142.03~-76.69,Z=6.56,P<0.05)、术后并发症(OR=0.42,95%CI:0.28~0.62,Z=4.38,P<0.05)、术后住院时间(MD=-3.31,95%CI:-4.16~-2.47,Z=7.66,P<0.05)、术后ALT(MD=-7.23,95%CI:-8.39~-6.07,Z=12.17,P<0.05)、AST(MD=-5.37,95%CI:-8.59~-2.14,Z=3.26,P<0.05)、TB(MD=-2.84,95%CI:-3.45~-2.23,Z=9.09,P<0.05)比较,差异均有统计学意义。亚组分析结果显示手术时间、术中出血量及术后住院时间的异质性主要来源于腹腔镜肝切除的难易程度。

结论

三维重建技术应用于腹腔镜肝癌肝切除术能提高手术安全性和疗效,缩短手术时间,减少术中出血量,降低术后并发症发生风险。

Objective

To explore the application value of three-dimensional reconstruction in laparoscopic hepatectomy for liver cancer.

Methods

Literature in Chinese or English about randomized controlled study (RCT), cohort study or case-control study of three-dimensional reconstruction combined with laparoscopic hepatectomy for liver tumors was retrieved in PubMed, Cochrane Library, Embase, SinoMed, CNKI, Wanfang and Chongqing VIP databases from the inception of database to February 2019. The Chinese and English searching terms included hepatoma, liver cancer, hepatectomy, laparoscope and three-dimensional reconstruction. Clinical data including perioperative condition and postoperative liver function were extracted for Meta-analysis.

Results

8 articles of 534 patients were eventually included. Among them, 245 cases were assigned into the experimental group in which three-dimensional reconstruction was used and 289 cases in the control group. Meta-analysis showed that the operation time (MD=-36.48, 95%CI:-52.00 to -20.96, Z=4.61, P<0.05), intraoperative blood loss (MD=-109.36, 95%CI:-142.03 to -76.69, Z=6.56, P<0.05), incidence of postoperative complications (OR=0.42, 95%CI: 0.28 to 0.62, Z=4.38, P<0.05), length of postoperative hospital stay (MD=-3.31, 95%CI:-4.16 to -2.47, Z=7.66, P<0.05), postoperative ALT level (MD=-7.23, 95%CI: -8.39 to -6.07, Z=12.17, P<0.05), postoperative AST level (MD=-5.37, 95%CI:-8.59 to -2.14, Z=3.26, P<0.05) and postoperative TB level (MD=-2.84, 95%CI:-3.45 to -2.23, Z=9.09, P<0.05) significantly differed between two groups. Subgroup analysis showed that the heterogeneity of operation time, intraoperative blood loss and length of postoperative hospital stay was mainly caused by the difficulty of laparoscopic hepatectomy.

Conclusions

Application of three-dimensional reconstruction in laparoscopic hepatectomy for liver cancer can improve the surgical safety and efficacy, shorten the operation time, reduce the intraoperative blood loss and lower the risk of postoperative complications.

表1 纳入文献的基本特征及质量评价
图1 以术后并发症为结局指标的文献发表偏倚漏斗图
图2 实验组与对照组腹腔镜肝切除手术时间Meta分析
图3 复杂组与非复杂组腹腔镜肝切除手术时间Meta分析
图4 复杂组与非复杂组腹腔镜肝切除术后住院时间Meta分析
图5 复杂组与非复杂组腹腔镜肝切除术中出血量Meta分析
[1]
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424.
[2]
McGlynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability[J]. Clin Liver Dis, 2015, 19(2):223-238.
[3]
张雄杰,张能平. 三维重建联合腹腔镜行肝精准切除治疗原发性肝癌疗效[J]. 中国现代普通外科进展, 2019, 22(10):781-784.
[4]
贾萌. 三维重建技术联合腹腔镜精准肝切除术治疗原发性肝癌的临床疗效观察[J]. 肝胆外科杂志, 2017, 25(2):115-117, 122.
[5]
Zhang P, Luo H, Zhu W, et al. Real-time navigation for laparoscopic hepatectomy using image fusion of preoperative 3D surgical plan and intraoperative indocyanine green fluorescence imaging[J]. Surg Endosc, 2020, 34(8):3449-3459.
[6]
梁霄,茅棋江,梁岳龙, 等. 肝脏三维重建技术在腹腔镜肝切除术中的应用价值[J]. 中华消化外科杂志, 2019, 18(5):439-446.
[7]
杨闯,张永川,李华国, 等. 肝脏三维可视化技术联合腹腔镜解剖性肝切除术治疗肝脏肿瘤的临床效果[J]. 中国老年学杂志, 2018, 38(6):1342-1345.
[8]
张焱,向国安,袁庆功, 等. 三维重建对右侧肝脏占位性病变精准肝切除微创手术效果的影响[J]. 医学临床研究, 2018, 35(11):2091-2093.
[9]
茅棋江. 三维重建技术在腹腔镜肝切除中的应用[D]. 杭州:浙江大学附属邵逸夫医院, 2017:1-28.
[10]
邵贤,贾乃昕,陈佳慧, 等. 应用三维重建及虚拟肝切除系统的腹腔镜下精准切除右肝肿瘤[J]. 中华普通外科杂志, 2016, 31(7): 538-540.
[11]
Hasegawa Y, Wakabayashi G, Nitta H, et al. A novel model for prediction of pure laparoscopic liver resection surgical difficulty[J]. Surg Endosc, 2017, 31(12):5356-5363.
[12]
Kawaguchi Y, Fuks D, Kokudo N, et al. Difficulty of laparoscopic liver resection: proposal for a new classification[J]. Ann Surg, 2018, 267(1):13-17.
[13]
Ryu T, Honda G, Kurata M, et al. Perioperative and oncological outcomes of laparoscopic anatomical hepatectomy for hepatocellular carcinoma introduced gradually in a single center[J]. Surg Endosc, 2018, 32(2):790-798.
[14]
Dong J, Yang S, Zeng J, et al. Precision in liver surgery[J]. Semin Liver Dis, 2013, 33(3):189-203.
[15]
中国研究型医院学会肝胆胰外科专业委员会. 精准肝切除术专家共识[J]. 中华消化外科杂志, 2017, 16(9):883-893.
[16]
Ciria R, Ocaña S, Gomez-Luque I, et al. A systematic review and meta-analysis comparing the short- and long-term outcomes for laparoscopic and open liver resections for liver metastases from colorectal cancer[J]. Surg Endosc, 2020, 34(1):349-360.
[17]
Meng X, Xu Y, Pan Y, et al. Open versus laparoscopic hepatic resection for hepatocellular carcinoma: a systematic review and meta-analysis[J]. Surg Endosc, 2019, 33(8):2396-2418.
[18]
Ciria R, Cherqui D, Geller DA, et al. Comparative short-term benefits of laparoscopic liver resection: 9000 cases and climbing[J]. Ann Surg, 2016, 263(4):761-777.
[19]
方驰华,刘允怡,蔡伟. 数字医学技术在我国普通外科应用的现状和前景[J]. 中华外科杂志, 2017, 55(1):11-14.
[1] 燕速, 霍博文. 腹腔镜食管胃结合部腺癌根治性切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 13-13.
[2] 母德安, 李凯, 张志远, 张伟. 超微创器械辅助单孔腹腔镜下脾部分切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 14-14.
[3] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[4] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[5] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[6] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[7] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[8] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[9] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[10] 王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[11] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[12] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
[13] 郭兵, 王万里, 何凯, 黄汉生. 腹腔镜下肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 143-143.
[14] 李凯, 陈淋, 苏怀东, 向涵, 张伟. 超微创器械在改良单孔腹腔镜巨大肝囊肿开窗引流及胆囊切除中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 144-144.
[15] 魏丽霞, 张安澜, 周宝勇, 李明. 腹腔镜下Ⅲb型肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 145-145.
阅读次数
全文


摘要